These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2526010)

  • 1. Therapy of serious gram-positive infections with teicoplanin.
    Davies AJ; Stone JM; Synott M
    Drugs Exp Clin Res; 1989; 15(1):29-31. PubMed ID: 2526010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of teicoplanin in neutropenic patients: values and limits].
    Espinouse D; Chomarat M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teicoplanin for therapy of gram-positive infections in neutropenic patients.
    Verhagen C; De Pauw BE
    Int J Clin Pharmacol Res; 1987; 7(6):491-8. PubMed ID: 2964418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases].
    Dureux JB; Canton P; Chavanet P; Chippaux C; Dupeyron JP; Estavoyer JM; Giorgi C; Jaeger A; Jehl F; Kazmierzack A
    Pathol Biol (Paris); 1987 May; 35(5):511-5. PubMed ID: 2956564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teicoplanin in the therapy of staphylococcal neuroshunt infections.
    Maserati R; Cruciani M; Azzini M; Carnevale C; Suter F; Concia E
    Int J Clin Pharmacol Res; 1987; 7(3):207-13. PubMed ID: 2954919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin--domiciliary use in surgical infections.
    Rubinstein E
    Eur J Surg Suppl; 1992; (567):27-9. PubMed ID: 1381638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
    LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
    Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
    Webster A; Wilson AP; Treasure T; Grüneberg RN
    Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of teicoplanin as antimicrobial treatment of severe nosocomial infections caused by gram-positive bacteria: a preliminary study.
    Micozzi A; Venditti M; Brandimarte C; Baiocchi P; Martino P; Serra P
    Chemioterapia; 1988 Apr; 7(2):101-4. PubMed ID: 2969302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open study of teicoplanin in gram-positive infections.
    Walsh B; Drabu YJ; Mehtar S; Blakemore PH
    Int J Clin Pharmacol Res; 1988; 8(2):99-100. PubMed ID: 2967801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy and safety of teicoplanin in gram-positive infections: a multicentre study.
    Lang E; Schäfer V; Schaaf B; Dennhardt R
    Scand J Infect Dis Suppl; 1990; 72():54-60. PubMed ID: 2151067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R; Paganini H; Gómez S; Casimir L; Stamboulian D
    Medicina (B Aires); 2002; 62 Suppl 2():48-51. PubMed ID: 12481489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of teicoplanin in gram-positive pulmonary infections.
    Sanduzzi A; Nani E; Sarno M; Vatrella A; Parrella R; Mattiello A
    J Chemother; 1991 Jan; 3 Suppl 1():224-6. PubMed ID: 12041771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopeptides in the treatment of staphylococcal infections.
    Daschner FD; Kropec A
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spanish experience with teicoplanin.
    Fernández-Guerrero M; Gobernado M; Ariza J; Williams A
    Scand J Infect Dis Suppl; 1990; 72():38-44. PubMed ID: 2151066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the use of teicoplanin for staphylococcal infections in immunocompetent and immunodepressed patients].
    Catania S; Trinchieri V; Lanzalone CM; Causo T; Allegra C; Catania N; Cirelli A
    Riv Eur Sci Med Farmacol; 1990 Dec; 12(6):319-24. PubMed ID: 2151886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Staphylococcal infection in the newborn: teicoplanin therapy].
    Fanos V; Khoory BJ; Danieli D; Padovani EM
    Pediatr Med Chir; 1993; 15(6):579-82. PubMed ID: 8197017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.